Heat shock proteins are proposed to limit injury resulting from diverse environmental stresses, but direct metabolic evidence for such a cytoprotective function in vertebrates has been largely limited to studies of cultured cells. We generated lines of transgenic mice to express human 70-kDa heat shock protein constitutively in the myocardium. Hearts isolated from these animals demonstrated enhanced recovery of high energy phosphate stores and correction of metabolic acidosis following brief periods of global ischemia sufficient to induce sustained abnormalities of these variables in hearts from nontransgenic littermates. These data demonstrate a direct cardioprotective effect of 70-kDa heat shock protein to enhance postischemic recovery of the intact heart.
Previous studies have demonstrated a cytoprotective function for heat shock proteins during thermal stress or energy deprivation in cultured cells (1) (2) (3) (4) (5) (6) . Expression of endogenous 70-kDa heat shock protein (hsp7o) is induced by ischemia in intact hearts (6, 7) , and this response correlates with a reduced susceptibility to ischemic injury (8) (9) (10) (11) . Preconditioning stimuli that induce hsp70, however, also invoke other responses that may mitigate myocardial dysfunction resulting from ischemia (12) (13) (14) . The proposition that stress proteins exert direct cardioprotective effects remained conjectural until the development of transgenic mouse models, which provide an opportunity for rigorous tests of this hypothesis by examination of relationships between heat shock protein expression and various descriptors of ischemic injury. The goal of this work was to assess the effects of forced constitutive expression of hsp70 on recovery of high-energy phosphate metabolism (assessed by 31P NMR spectroscopy) following periods of global ischemia in isolated perfused mouse hearts.
MATERIALS AND METHODS
Transgenic Mouse Lines. Transgenic mice (FVB/N strain) were generated by standard methods using a linearized DNA fragment containing full-length human inducible hsp7O cDNA (15) inserted downstream of the human /3-actin promoter (16) and upstream assay. RNA was extracted from myocardial tissue samples by standard methods, and cDNA was synthesized with reverse transcriptase by using an oligo(dT) primer. Primer pairs were specific either for murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (loading control) or human hsp7o cDNA and generated amplification products of 400 or 496 bp, respectively. RNA isolated from heat shocked human HeLa cells served as a positive control. The identity of the PCR product generated from the transgenic hearts when using human hsp7o primer pairs was confirmed by cleavage with Cla I, the restriction site for which is absent from the murine hsp70 sequence, to produce a 453-bp fragment. Proteins extracted from whole hearts were separated by isoelectric focusing and SDS/PAGE, and two-dimensional immunoblot assays (17) were conducted by using an exquisitely sensitive rabbit antihuman inducible hsp7o antibody.
Langendorff 31P NMR Spectroscopic Methods. A General Electric model GN 500 (11.75 T) spectrometer operating at 202 MHz for 31p was equipped with a 10-mm probe which could be tuned to either 23Na or 31p. Magnetic field homogeneity was adjusted by using the 23Na free-induction decay; a linewidth of approximately 12 Hz was usually obtained. Fully relaxed 31p spectra were acquired with a 11.75-sec interpulse delay, using a 900 pulse for a total of 360 acquisitions over 1.2 h. Subsequent 31p spectra were acquired with a 250-msec interpulse delay for a total of 360, 600, or 1200 acquisitions over 3, 5, or 10 min, respectively. 31p spectra were obtained during three intervals: at baseline after equilibration, during global ischemia for 6, 10, 20, or 25 min, and during 30 min of recovery.
Abbreviations: hsp7O, 70-kDa heat shock protein; TG, transgenic; WT, wild type.
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Data Analysis. Investigators performing the perfusion studies were blinded to the genotype of the initial experimental animals until after analysis of spectroscopic data was complete. A complete set of spectroscopic data was obtained from 32 heterozygote transgenic animals (TG) and 19 wild-type nontransgenic littermates (WT). Initial studies of hearts subjected to 6 or 10 min of ischemia (n = 19 TG and 10 WT) were conducted by using animals from both of the two independent transgenic lines representing different chromosomal insertion sites (lines 813 and 820), and no differences were apparent between the two transgenic lines. Consequently, in subsequent studies in which hearts were subjected to 20 or 25 min of ischemia (n = 13 TG and 9 WT), a single line of transgenic animals was examined (TG line 813).
Three 31p spectra were summed at baseline and at the end of recovery to enhance signal to noise for the measurement of the resonance areas for phosphocreatine, inorganic phosphate, and ,3-ATP, which were measured in each spectrum by using an automated curve fitting routine. pH was calculated from the chemical-shift difference between the inorganic phosphate and the phosphocreatine peaks (19) . Differences among the pooled data from the three groups subjected to 6 
RESULTS
The human hsp70 transgene was transcribed in hearts isolated from both of the two transgenic mouse lines studied in this analysis (Fig. 1A) . Expression of human inducible hsp70 protein in these hearts was detected by two-dimensional immunoblot analysis (Fig. 1B) . No differences in transgene expression were evident between the two independent transgenic lines. Of note, we did not detect the mouse inducible hsp70 in wild-type hearts as others have shown when using this antibody (20) . This may be related to the smaller sample of protein used in our assay (600 ,ug of total protein from each heart was used for immunoblots, except for no. 6, which contained 1.2 mg; Fig. 1B ). Overexpression of human hsp70 expression did not appear to interfere with normal development: body weights, gross appearance of internal organs at necropsy, and histological appearance of the hearts from transgenic animals were indistinguishable from those of nontransgenic littermates. A clear phenotypic difference resulting from expression of the transgene was revealed, however, by examination of isolated hearts subjected to ischemic stress. Representative 31P NMR spectra from wild-type and transgenic hearts acquired at baseline, after 6 min of global ischemia, or following 30 min of reperfusion are shown in Fig.  2 . In the absence of ischemia, all metabolic variables were stable for up to 120 min of perfusion (data not shown). The 6-min duration of ischemia was sufficient to deplete highenergy phosphate stores and induce acidosis in both transgenic and wild-type hearts. In addition, developed pressure fell to zero in all hearts during the ischemic period.
During recovery, however, significant differences were observed in the transgenic hearts compared with the wild-type controls. Representative spectra are shown in Fig. 2 and demonstrate that 1-ATP and phosphocreatine levels were increased and that inorganic phosphate levels declined toward baseline values in the transgenic heart, while severe abnormalities of these variables persisted in the wild-type control heart. This improved recovery of high-energy phosphate stores in both the 813 and 820 lines of transgenic hearts was significant in hearts subjected to 6 or 10 min of global ischemia and 30 min of reperfusion. This effect of transgene expression was lost, The 496-and 453-bp fragments represent intact and Cla I-digested human hsp70 cDNA, respectively. The 400-bp fragment represents glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, reverse transcribed from the endogenous mouse transcript, and serves as a control for the integrity of RNA samples from each heart. MSM, molecular size marker. (B) Two-dimensional immunoblot analysis of hsp7o protein expression in transgenic and wild-type hearts. Protein extracted from heat-shocked HeLa cells was mixed with protein extracted from a wild-type mouse heart to provide an unambiguous source of human hsp70 as a positive control. The rabbit anti-human polyclonal antibody crossreacts with human inducible hsp7o which is present in transgenic hearts but not in wild-type hearts (600 ,ug of total protein from each heart was used for immunoblots, except for no. 6, which contained 1.2 mg). A similar pattern was observed in four representative animals in both of the two independent transgenic lines.
however, after longer durations of global ischemia (20 or 25 min). Data illustrating recovery of ATP concentrations are summarized in Fig. 3 . While there was no difference in pH among the two transgenic lines and the wild-type hearts at baseline, ischemia-induced intracellular acidosis was corrected during recovery from ischemia in transgenic hearts following 6 min of ischemia (pH 7.06 ± 0.07 vs. pH 6.90 ± 0.10; P < 0.05). These differences were not observed in hearts experiencing more prolonged ischemia. The salutary effects of hsp70 transgene expression on metabolic recovery were accompanied by enhanced recovery of contractile function. After 6 min of global ischemia, the recovery of developed pressure (systolic pressure minus diastolic pressure) at 30 min was essentially complete in both transgenic lines while wild-type hearts recovered to only 40% of baseline (data not shown). Following longer time periods of ischemia, however, the differences in recovery of mechanical function were not significantly different among all hearts.
DISCUSSION
Major stress proteins, including but not limited to hsp7O, are clearly involved in promoting thermotolerance in prokaryotes, unicellular eukaryotes, insects, and in mammalian cell lines (21) . In addition, we (1) and others (2) have previously demonstrated salutary effects of hsp70 on cell survival and metabolic recovery in cultured cells subjected to conditions simulating ischemia. Our present findings demonstrate that metabolic recovery from bona fide ischemia is enhanced by forced expression of hsp70 in the more complex environment of the intact heart and provide direct evidence for a cytoprotective function for stress proteins in tissues, as opposed to isolated cells, of vertebrate organisms. These findings compli- ment studies done concurrently in two separate laboratories with transgenic mouse lines which showed enhanced mechanical recovery in isolated perfused mouse hearts which overexpressed hsp70 (20, 22) .
The molecular basis for the cardioprotective activity of hsp7O remains to be established, but presumably is related to enhanced refolding to functional conformations of critical cellular proteins that become partially denatured during the ischemic stress. Studies in cell-free systems have demonstrated an enhancing effect of major stress proteins on recovery of enzymatic function of purified proteins following thermal denaturation (23, 24) . In addition, based on the chaperone function of hsp70 with respect to nascent polypeptides (25) (26) (27) , a greater abundance of hsp70 in the recovery period may promote more rapid replacement of irreversibly damaged proteins with newly synthesized polypeptides.
Our study design did not permit systematic assessment of a dose-response relationship between concentrations of hsp70 and indices of myocardial recovery following ischemia. However, the magnitude of overexpression of hsp70 is sufficient to evoke favorable effects. Thus, the constitutive overexpression of human hsp70 transgene that appears not to alter the induction of endogenous hsp70 gene expression (20, 22) is directly responsible for the observed phenotype in postischemic metabolic recovery. This result is also consistent with previous studies in rat or rabbit hearts preconditioned with heat shock 24 h before coronary occlusion in which cardioprotective effects were associated with a similarly induction of expression of endogenous hsp70 (8) (9) (10) .
Enhanced metabolic recovery resulting from expression of the hsp7O transgene in the intact heart was not observed in hearts subjected to longer durations of ischemia (-20 min 1, 2, 4) . Future studies of relationships between expression of hsp70 and cellular recovery from ischemia or other stresses should consider the potentially narrow concentration range of hsp70 that may evoke favorable, as opposed to deleterious, effects. The observation that forced expression of hsp7O enhances recovery from ischemic stress in the intact heart has potential clinical implications (11, 28) . Preconditioning maneuvers or gene transfer strategies to augment expression of heat shock proteins could provide clinical benefits to patients undergoing surgical or catheter-based procedures that involve a high risk of myocardial ischemia.
